Forte Biosciences, Inc. · NASDAQ:FBRX
Affinity Asset Advisors, LLC reported a 6.70% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Jan 22, 2026 · Filed Jan 29, 2026
Affinity Asset Advisors, LLC reported a 6.70% stake in Forte Biosciences, Inc., 834,964 shares, as a passive investor on Jan 22, 2026. Filed Jan 29, 2026 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 834,964
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Affinity Asset Advisors, LLC | 6.70% | 834,964 |
| Michael Cho | 6.70% | 834,964 |
Source
Related
- Forte Biosciences, Inc.
- Affinity Asset Advisors, LLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · May 14, 2026
- Schedule 13G · Affinity Asset Advisors, LLC · Dec 23, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026